Patents by Inventor Andreas Plaitakis

Andreas Plaitakis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for diagnosis of glutamate dehydrogenase disorders
    Patent number: 8361728
    Abstract: Methods and compositions for diagnosis and treatment of neurodegenerative disorders are disclosed. The methods and compositions apply the discovery of the correlation between an hGDH2 gene polymorphism and the occurrence of atypical Parkinson's Disease.
    Type: Grant
    Filed: June 25, 2009
    Date of Patent: January 29, 2013
    Inventor: Andreas Plaitakis
  • Method for treatment and diagnosis of glutamate dehydrogenase disorders
    Publication number: 20100166880
    Abstract: Methods and compositions for diagnosis and treatment of neurodegenerative disorders are disclosed. The methods and compositions apply the discovery of the correlation between an hGDH2 gene polymorphism and the occurrence of atypical Parkinson's Disease.
    Type: Application
    Filed: June 25, 2009
    Publication date: July 1, 2010
    Inventor: Andreas Plaitakis
  • Administration of amino acids as treatment for neurodegenerative disorders
    Patent number: 5028622
    Abstract: A treatment and composition for preventing in mammals the progressive exacerbation of symptoms associated with neurodegenerative disorders characterized by abnormal glutamate metabolism, elevated levels of peripheral glutamate or altered glutamate receptor characteristics. The treatment is comprised of the administration of compositions comprised of amino acids that are effective in retarding the development of symptoms associated with neurodegenerative disorders, presumably by activating the enzyme glutamate dehydrogenase. In the preferred embodiment, the branched chain amino acids L-leucine, L-isoleucine, and L-valine are disclosed as effective therapeutic agents for the treatment of amyotrophic lateral sclerosis.
    Type: Grant
    Filed: June 6, 1989
    Date of Patent: July 2, 1991
    Assignee: Ajinomoto Company, Inc.
    Inventor: Andreas Plaitakis